Aligos Therapeutics, Inc. (ALGS) ownership: Top institutional holder: Deep Track Capital, LP ($3.30M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Deep Track Capital, LP | 444110.00 | $3.30M | 2026-03-31 |
| Alyeska Investment Group, L.P. | 412000.00 | $3.06M | 2026-03-31 |
| Sio Capital Management, LLC | 327237.00 | $2.43M | 2026-03-31 |
| MARSHALL WACE, LLP | 267135.00 | $1.98M | 2026-03-31 |
| VANGUARD GROUP INC | 200395.00 | $1.87M | 2025-12-31 |
| BANK OF AMERICA CORP /DE/ | 229754.00 | $1.71M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 178262.00 | $1.32M | 2026-03-31 |
| Woodline Partners LP | 177362.00 | $1.32M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-09 | |
| Sell | null | 2026-03-09 | |
| Sell | null | 2026-03-09 | |
| Sell | null | 2026-03-09 | |
| Sell | null | 2026-03-09 | |
| Sell | null | 2026-03-09 | |
| Sell | null | 2026-03-09 | |
| Sell | null | 2026-03-09 |
Back to ALGS overview · ALGS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.